Registry of Etanercept Use in Patients With Rheumatoid Arthritis in Clinical Practice in Taiwan
NCT ID: NCT00888576
Last Updated: 2012-02-08
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
441 participants
OBSERVATIONAL
2008-12-31
2011-12-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Study Evaluating The Use Of Etanercept In Patients With Ankylosing Spondylitis
NCT00544557
Study Evaluating the Safety of Enbrel (Etanercept)
NCT00683384
Study Evaluating the Efficacy and Safety of Etanercept in Chinese Subjects With Rheumatoid Arthritis
NCT00443950
Real World Effectiveness of Abatacept in Rheumatoid Arthritis Patients: a Prospective, Single-arm, Open-label, Multi-center Observational Study in Taiwan
NCT02335606
Good EULAR Response In Patients With Early Rheumatoid Arthritis
NCT01558089
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
1
Non-intervention
No interventions assigned to this group
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Main Inclusion Criteria: 1) Male or female patients aged \> 20 years; 2) Patients who have already been selected and approved under the Taiwan National Health Insurance Program to receive 24 weeks of etanercept for rheumatoid arthritis. Main
Exclusion Criteria:
Exclusion Criteria: None
20 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Pfizer
INDUSTRY
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Pfizer CT.gov Call Center
Role: STUDY_DIRECTOR
Pfizer
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Pfizer Investigational Site
Changhua, Changhua County, Taiwan
Pfizer Investigational Site
Changhua, Changhua, Taiwan
Pfizer Investigational Site
Lukang Zhen, Changhua, Taiwan
Pfizer Investigational Site
Dalin, Chia-Yi, Taiwan
Pfizer Investigational Site
Putz, Chiayi, Taiwan
Pfizer Investigational Site
Kaohsiung City, Kaohsiung, Taiwan
Pfizer Investigational Site
Kaohsiung City, Kaohsiung, Taiwan
Pfizer Investigational Site
Niao Sung Hsiang, Kaohsiung, Taiwan
Pfizer Investigational Site
Keelung, Keelung, Taiwan
Pfizer Investigational Site
Taichung, Taichung, Taiwan
Pfizer Investigational Site
Taichung, Taichung, Taiwan
Pfizer Investigational Site
Taipei, Taipei, Taiwan
Pfizer Investigational Site
Taipei TOC, Taiwan, Taiwan
Pfizer Investigational Site
Guishanli, Taoyuan, Taiwan
Pfizer Investigational Site
Taoyuan District, Taoyuan, Taiwan
Pfizer Investigational Site
Hualien City, , Taiwan
Pfizer Investigational Site
Taichung, , Taiwan
Pfizer Investigational Site
Tainan City, , Taiwan
Pfizer Investigational Site
Taipei, , Taiwan
Pfizer Investigational Site
Taipei, , Taiwan
Pfizer Investigational Site
Taipei, , Taiwan
Pfizer Investigational Site
Taipei, , Taiwan
Pfizer Investigational Site
Taoyuan District, , Taiwan
Countries
Review the countries where the study has at least one active or historical site.
Related Links
Access external resources that provide additional context or updates about the study.
To obtain contact information for a study center near you, click here.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
0881A1-4445
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.